TRAVERSE BIOSCIENCES, INC.
Biotech · Private
TRB-N0224, a proprietary chemically modified curcumin small-molecule drug candidate that modulates matrix metalloproteinases and pro-inflammatory cytokines to treat inflammatory periodontal disease
- Grants
- $1.5M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Evaluation of TRB-N0224, a Proprietary Chemically Modified Curcumin, for the Treatment of Periodontal Disease in a LPS-Induced Rat Model | $205,709 | |
| Federal grant | Department of Health and Human Services · Phase II · Pre-Clinical Safety and Efficacy of TRB-N0224 for the Treatment of Periodontal Disease | $888,810 | |
| Federal grant | Department of Health and Human Services · Phase II · Pre-Clinical Safety and Efficacy of TRB-N0224 for the Treatment of Periodontal Disease | $431,622 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2205 | SHAL TECHNOLOGIES, INC. | — | — |
| 2206 | Cognosetta, Inc. | — | — |
| 2207 | RJS Biologics L.L.C. | — | — |
| 2208 | TRAVERSE BIOSCIENCES, INC. | — | — |
| 2209 | ARIETIS CORPORATION | — | — |
| 2210 | MBX Biosciences | — | $95M |
| 2211 | TECTARIA BIO LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.